Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Shares Issued (2020 - 2024)

SELLAS Life Sciences (SLS) has disclosed Shares Issued for 9 consecutive years, with $1000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Shares Issued changed N/A to $1000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $560000.0, a 423.36% increase, with the full-year FY2024 number at $560000.0, up 423.36% from a year prior.
  • Shares Issued was $1000.0 for Q4 2024 at SELLAS Life Sciences, up from -$26.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $26.6 million in Q2 2024 to a low of -$26.0 million in Q3 2024.
  • A 5-year average of $783470.6 and a median of $47000.0 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 1826.0% in 2022, then crashed 16077.64% in 2024.
  • SELLAS Life Sciences' Shares Issued stood at -$5.9 million in 2020, then soared by 100.84% to $50000.0 in 2021, then skyrocketed by 1826.0% to $963000.0 in 2022, then tumbled by 116.72% to -$161000.0 in 2023, then soared by 100.62% to $1000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLS's Shares Issued are $1000.0 (Q4 2024), -$26.0 million (Q3 2024), and $26.6 million (Q2 2024).